Efficacy and safety of efinopegdutide in adults with metabolic dysfunction-associated steatohepatitis and stage 2-3 fibrosis: a phase 2b, randomised, placebo-controlled study. (linkinghub.elsevier.com)

Authors: Lawitz E … Schattenberg JM Journal: The Lancet Published: 2026-11-09 DOI: https://doi.org/10.1016/S0140-6736(26)02043-X